Bioanalysis

Papers
(The median citation count of Bioanalysis is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
2024 White Paper on Recent Issues in Bioanalysis: Evolution of Immunogenicity Assessment beyond ADA/NAb; Regulated Genomic/NGS Assays; Hypersensitivity Reactions; Minimum Noise Reduction; False Positi27
Improved real-world UHPLC-MS/MS iohexol analysis; thawed samples, improved calibration curve, and additional matrices26
2022 White Paper on Recent Issues in Bioanalysis: ICH M10 BMV Guideline & Global Harmonization; Hybrid Assays; Oligonucleotides & ADC; Non-Liquid & Rare Matrices; Regulatory Inputs ( 25
2022 White Paper on Recent Issues in Bioanalysis: Fda Draft Guidance on Immunogenicity Information in Prescription Drug Labeling, Lnp & Viral Vectors Therapeutics/Vaccines Immunogenicity, Prolonga25
Feedback from a workshop by the European Bioanalysis Forum on assay validation requirements for in vitro assays following the publication of ICH M12 guideline – a plea f25
Two decades of immunocapture liquid chromatography tandem mass spectrometry for pharmaceutical discovery and development: reflections and recommendations for optimal deployment24
Quantitation of Ivosidenib in Human Plasma Via LC–MS/MS and its Application in Clinical Trials24
Approaches to Overcome the Challenge of Sample Stability for Flow Cytometry Analysis in Clinical Trials22
Assay pH and Critical Reagent Optimization in Measuring Concentrations of a Monoclonal Antibody and its Target20
Volumetric Absorptive Microsampling as An Effective Microsampling Technique for LC–MS/MS Bioanalysis of Biomarkers in Drug Discovery20
LC–MS/MS method for quantification of raspberry ketone in rat plasma: application to preclinical pharmacokinetic studies19
Quantification of a promising JNK inhibitor and nitrovasodilator IQ-1 and its major metabolite in rat plasma by LC–MS/MS18
Conference Report from the European Bioanalysis Forum Workshop: toward harmonized implementation of the ICH M10 guideline17
Liquid chromatographic methods in the determination of inosine monophosphate dehydrogenase enzyme activity: a review17
Novel microchip electrophoresis–contactless conductivity method for detection and characterization of extracellular vesicles enriched for exosomes and microvesicles16
Greenness assessment of microextraction techniques in therapeutic drug monitoring14
Covalent organic frameworks: spotlight on applications in the pharmaceutical arena14
Development, validation and application of a liquid chromatography–tandem mass spectrometry method for quantifying lurasidone in dried blood spot samples14
Single-Analyte Biomarker Assays for Pharmacodynamic or Safety Assessment During Biotherapeutic Development13
Critical reagent considerations for immunogenicity assay development for bispecific biotherapeutic candidates13
A Blood-Based, Metabolite and Demographic Characteristic Markers Panel For The Diagnosis of Alzheimer's Disease13
Decentralized Clinical Trial Design Using Blood Microsampling Technology for Serum Bioanalysis12
Calprotectin as a Biomarker in Rheumatoid Arthritis: The Potential Predictive Value of Response to Treatment12
LC–MS Bioanalysis of Protein Biomarkers and Protein Therapeutics in Formalin-Fixed Paraffin-Embedded Tissue Specimens12
Feedback from the Sixth European Bioanalysis Forum Young Scientist Symposium11
Meet the Editorial Board – An Interview with Min Meng and Transitions from Small Regional Labs to Global CRO11
Prediction of frozen virus stability based on degradation mechanisms, real-time data and modeling11
Immunocapture LC–MS(/MS) Assays for Biotherapeutic and Biomarker Proteins: The European Bioanalysis Forum Continuing Discussions on Scientific and Regulatory Challenges11
Free Hemoglobin Determination at Patients’ Bedside to Evaluate Hemolysis11
Multidimensional Chromatography Platforms: Status and Prospects10
Stability of Nafamostat in Intravenous Infusion Solutions, Human Whole Blood and Extracted Plasma: Implications for Clinical Effectiveness Studies10
Validation of High-Throughput, Semiquantitative Solid-Phase Sarscoronavirus-2 Serology Assays in Serum and Dried Blood Spot Matrices10
An Ultrasensitive LC–MS/MS Method and Application to Clinical Dose-Range Finding for Glycopyrrolate via an e-Nebulizer10
Recommendations for the Content and Management of Certificates of Analysis for Reference Standards from the GCC for Bioanalysis9
Criteria of Slope and Endogenous Level for Selection of Matrix in the Quantitation of Endogenous Compounds by LC-MS/MS9
Validation of low-volume sampling devices for pharmacokinetic analysis: technical and logistical challenges and solutions9
Label-Free Immunosensing of Telomerase Using Bio-Conjugation of Biotinylated Antibody to Poly(Chitosan) Gold Nanoparticles9
A platform immunoassay for the quantification of biotherapeutics with glycine-serine linkers8
Critical Reagents: Evolution of WRIB Recommendations on Critical Reagents8
A Biomarker Assay Validation Approach Tailored to The Context of Use and Bioanalytical Platform8
Solutions for Hematocrit Bias in Dried Blood Spot Hormone Analysis8
The advantages of working with a central laboratory for conducting clinical trials8
Towards a More Patient-Centric Assessment of Immunogenicity for Low-Risk Biologics in Immuno-Oncology Clinical Trials8
Advancements in Practical and Scientific Bioanalytical Approaches to Metabolism Studies in Drug Development8
Degradation of Vancomycin in External Quality Assessment Samples is a Factor to Underestimate Its Concentration7
2022 White Paper on Recent Issues in Bioanalysis: Enzyme Assay Validation, BAV for Primary End Points, Vaccine Functional Assays, Cytometry in Tissue, LBA in Rare Matrices, Complex NAb Assays, Spectra7
Analytical Techniques for Monitoring of Toluene and Xylene Exposure Biomarkers Hippuric Acid and Methylhippuric Acid in Human Urine Samples7
Uncovering the Green Frontier: Harnessing Deep Eutectic Solvents for Sustainable Bioanalysis7
Technique Development of High-Throughput and High-Sensitivity Sample Preparation and Separation for Proteomics7
Bioanalysis by LC-MS/MS and Preclinical Pharmacokinetic Interaction Study of Ribociclib and Oleanolic Acid7
Biomarker Context-Of-Use: How Organizational Design Can Impact the Implementation of the Appropriate Biomarker Assay Strategy7
Comparing Singlet and Duplicate Immunogenicity Assay in Human Plasma for Pembrolizumab Using Gyrolab®7
A Brave New World?7
Development and validation of an ELISA method for quantification of the anti-HER3 antibody HMBD-001 in human serum7
A Simple Isotope-Labeled UHPLC–MS/MS Assay for Simultaneous Quantification of Methotrexate, Imatinib and Dasatinib7
Microflow LC–MS/MS to improve sensitivity for antisense oligonucleotides bioanalysis: critical role of sample cleanness7
A Low-Voltage Electro-Membrane Extraction for Quantification of Imatinib and Sunitinib in Biological Fluids6
Challenges and Current Advances in the Methodology of Thyroglobulin Measurements6
Unique challenges required reassessment and alterations to critical reagents to rescue a neutralizing antibody assay6
Simultaneous estimation of rutin and donepezil through RP-HPLC: implication in pharmaceutical and biological samples6
Simple Method to Determine the Concentration and Incorporation Ratio of Ruthenium-Labeled Antibodies6
Single-Day Protein LC–MS Bioanalysis: Can Next-Generation Trypsins Cut It?6
The case for bioanalytical analyzer6
An LC-MS/MS method for the determination of Lifitegrast in human plasma and tear and its application in the pharmacokinetic study6
Novel Hydrophilic-Phase Extraction, HILIC and High-Resolution MS Quantification of an RNA Oligonucleotide in Plasma6
Determination of Favipiravir in Human Plasma using Homogeneous Liquid–Liquid Microextraction followed by HPLC/UV6
Peripheral blood mononuclear cells isolation from mouse and rabbit blood to quantify active nucleotide and define brincidofovir dose for smallpox5
Bioanalysis of INCB000928 in hemodialysate: prevention of nonspecific binding and validation of surrogate matrices5
Achieving Routine Application of Dried Blood Spots for Erythropoietin Receptor Agonist Analysis in Doping Control: Low-Volume Single-Spot Detection at Minimum Required Performance Level5
In Vitro Immunogenicity Prediction: Bridging between Innate and Adaptive Immunity5
Using Mitra Sampling to Support First-in-Human Pharmacokinetic Evaluations for PF-070590135
Quantification of Oxalate by Novel LC–MS/MS: Assay Development, Validation and Application in Lumasiran Clinical Trials5
Comparative pharmacokinetic study of Anisodamine Hydrobromide tablets and injection in septic acute lung injury rats5
Analysis of Tigecycline in the Cerebrospinal Fluid and Serum of Patients with Acinetobacter Baumannii Central Nervous System Infection5
Fabry Disease Biomarkers in Patients Switched From Enzyme-Replacement Therapy to Migalastat Oral Chaperone Therapy5
Evaluation of hemaPEN ® sampling device for measurement of cocaine and metabolites in capillary blood by LC-MS/MS5
Biomonitoring of Arsenic, Lead, Manganese and Mercury in Hair from a Presumably Exposed Uruguayan Child Population5
In Vitro Study and Pharmacokinetic Evaluation of Sitagliptin Phosphate Enantiomers in Rat Plasma5
Dried Matrix Spots in Forensic Toxicology5
Empowering Peptidomics: Utilizing Computational Tools and Approaches5
Challenges of Implementing Ultrahigh-Throughput Mass Spectrometry in Absorption, Distribution, Metabolism and Excretion Bioanalysis5
Validation of an HPLC Method for Estimation of Cefotaxime from Dried Blood Spot: Alternative to Plasma-Based PK Evaluation in Neonates5
LC–MS/MS Methods for Direct Measurement of Sepiapterin and Tetrahydrobiopterin in Human Plasma and Clinical Applications5
LC-MS/MS-based bioanalysis of branched-chain and aromatic amino acids in human serum5
Pertinence of microsampling in various nonclinical and clinical studies: the ICH perspective4
Development of a selective, sensitive and robust oxyntomodulin dual monoclonal antibody immunoassay4
Inclusion of dilution quality control samples in quantitative LC-MS bioanalysis4
Digital Image Colorimetry for Determination of Ethanol in Exhaled Breath Condensate4
Integrity and Efficiency: AbbVie’s Journey of Building an Integrated Nonregulated Bioanalytical Laboratory4
Simultaneous quantification of siRNA antisense and sense strands by hybrid liquid chromatography-mass spectrometry4
2023 White Paper on Recent Issues in Bioanalysis: EU IVDR 2017/746 Implementation/Impact, IVD/CDx/CLIA Approved Assays, High Dimensional Cytometry, Multiplexing Technologies, LBA Tissue Analysis, Vacc4
16 th GCC Closed Forum: ICH M10 implementation; NGS, qPCR/dPCR, flow cytometry validation; tissue biomarkers; IS response; immunogenicity harmonization; bioanalytica4
Development of LC–MS/MS Method for Cyanoenone Triterpenoid Determination to Support CNS Tissue Distribution Study4
Rapid Development of Analytical Methods for Evaluating Pandemic Vaccines: A Covid-19 Perspective4
LC–MS/MS Assay of Fluoropezil and Its Two Major Metabolites in Human Plasma: An Application to Pharmacokinetic Studies4
Development and validation of an LC–MS/MS method for D- and L-2-hydroxyglutaric acid measurement in cerebrospinal fluid, urine and plasma: application to glioma4
The European Bioanalysis Forum recommendation on establishing appropriate drug tolerance levels in antidrug antibody assays4
Role of miRNA-21 in cancer and its application in electrochemical bioanalysis4
Expanding Assay Range to Accommodate a Monoclonal Antibody Therapeutic Quantification in Blood and Cerebrospinal Fluid4
Highlights From the 25th International Reid Bioanalytical Forum4
2024 White Paper on Recent Issues in Bioanalysis: Three Way-Cross Validation; Urine Clinical Analysis; Automated Methods; Regulatory Queries on Plasma Protein Binding; Automated Biospecimen Management4
Signal-to-noise Ratio to Assess Magnitude, Kinetics and Impact on Pharmacokinetics of the Immune Response to an Adalimumab Biosimilar4
Solid-Phase Microextraction for Assessment of Plasma Protein Binding, a Complement to Rapid Equilibrium Dialysis4
Application of Novel Plasma Separation Filter Cards for Quantification of Nucleoside/Nucleotide Reverse Transcriptase Inhibitor Di/Triphosphates in Dried Blood Spots Using Lc–Ms4
Chromatographic analysis of ciprofloxacin and metronidazole in real human plasma: green analytical chemistry perspective4
Development of a sensitive LC-MS/MS assay to support human microdose study for an oral agonist of the GLP-1 receptor4
Assessing prognosis by quantifying FcγRIIa on fixed platelets4
Green Bioanalysis: An Innovative and Eco-Friendly Approach for Analyzing Drugs in Biological Matrices4
Good Clinical Practices in the Bioanalytical Laboratory4
Novel assay format for total anti-adeno-associated virus antibody detection with low capsid consumption and built-in specificity control4
Patient-centric clinical trials: collaboration and innovation in bioanalytical and clinical operations4
Application of a new volumetric microsampling device for quantitative bioanalysis of immunosuppression4
Validation and Application of Hybridization Liquid Chromatography-Tandem Mass Spectrometry Methods for Quantitative Bioanalysis of Antisense Oligonucleotides3
Less is More: An Ecological and Economic Point of View on Appropriate Use of Lab Testing for Covid-19 Patients3
Development of pseudotyped VSV-SARS-CoV-2 spike variants for the assessment of neutralizing antibodies3
Method Development Workflow for Quantifying Protein Biomarkers by Hybrid LC–MS/MS3
Assessment of alteration in antiviral plasma concentration across dialysis days: computational and analytical study3
Pitfalls in bioanalytical work with a Japanese CRO or sponsor: from a project risk management perspective3
Quantitation of Vistusertib by UHPLC-MS/MS in Rat Plasma and its Application to a Pharmacokinetic Study3
Development and Validation of LC–MS/MS Method for Quantitation of Sodium Oligomannate in Human Plasma, Urine and Feces3
Comparison of Pharmacokinetic Study Profiles of Insulin in Rat Plasma Through Conventional Sampling and Microsampling by Micro-LC–MS/MS3
Comprehensive Performance Evaluation of Ligand-Binding Assay–LC–MS/MS Method for Co-Dosed Monoclonal Anti-SARS-CoV-2 Antibodies (AZD7442)3
Deploying a Rapid Point-Of-Care Polymerase Chain Reaction Test for Sars-Cov-2 in a Clinical Research Unit to Ensure Healthy Volunteer Safety3
Bioanalysis of the Bicycle®Toxin Conjugate BT5528 and Released Monomethyl Auristatin E via Liquid Chromatography–Tandem Mass Spectrometry3
LC–MS/MS Analysis and Pharmacokinetics of Daidzein and its 7-O-Glucuronide in Rats After Oral Administration of 7-O-L-Valyl Carbamate Prodrug3
Development of an Immunoassay for Aglycosylated Murine IgG1 in Mouse Serum via Generation of a Specific Tool Antibody3
Stability of Nonsteroidal Anti-Inflammatory Drugs in Urine and Solution: Effects of Degradation on Analytical Assessment3
Development of a Novel Elisa to Detect Total Factor D in the Presence of High Levels of Pegylated Anti-Factor D Fab3
A New Method for the Therapeutic Drug Monitoring of Chlorpromazine in Plasma by Gas Chromatography–Mass Spectrometry Using Dispersive Liquid–Liquid Microextraction3
Feedback from the 8th European Bioanalysis Forum Young Scientist Symposium3
Lacidipine: Review of Analytical Methods Developed for Pharmaceutical Dosage forms and Biological Fluids3
A Validated Method for the Determination of Hematocrit in Dried Blood Spots Using Image Analysis3
Conquering PROTAC molecular design and drugability3
Harmonization of Vaccine Ligand Binding Assays Validation3
Conduct of Remote Inspections: Challenges and Progress3
Simultaneous Determination of Four Antibiotics in Human Plasma by High-Performance LC–MS/MS: Application to Therapeutic Drug Monitoring3
Quantitative Chromatographic Method Development for Residual Lidocaine in Topical Systems and Biological Samples3
Progress Towards Global Standardization for Quantitative Flow Cytometry3
Novel Sorptive Microextraction Approaches in Bioanalysis: The Paradigm of Endocrine Disruptors3
Iron oxide nanozymes as versatile analytical tools: an overview of their application as detection technique3
Bioanalysis of tucatinib and metabolite, and a five-way cross-validation to support clinical pharmacokinetic analysis2
Simultaneous Determination of Duloxetine and 4-Hydroxy Duloxetine Glucuronide in Human Plasma and Back-Conversion Study2
Small Extracellular Vesicle Biomarkers in Breast Cancer: A Real-Time Snapshot for Early Diagnosis and Prognosis?2
Understanding Drug–Protein Binding and ADME Studies for DMPK2
2021 White Paper on Recent Issues in Bioanalysis: TAb/NAb, Viral Vector CDx, Shedding Assays; CRISPR/Cas9 & CAR-T Immunogenicity; PCR & Vaccine Assay Performance; ADA Assay Comparability &2
Development and application of a multi-sugar assay to assess intestinal permeability2
Perspective on LC-MS(/MS) for biotherapeutic and biomarker proteins in research and regulated Bioanalysis: a consolidation of more than a decade of experience across the European Bioanalysis Forum com2
High-resolution mass spectrometry for glycoproteomics2
ELISA array-based immunoassay for multiplex detection of osteoporosis-relevant biomarkers2
Development, Validation and Application of an Ion-Pair Reversed-Phase Liquid Chromatography-Tandem Mass Spectrometry Method for the Quantification of Nusinersen2
Advancing the Use of Molecularly Imprinted Polymers in Bioanalysis: The Selective Extraction of Cotinine in Human Urine2
Quantification of levetiracetam in plasma and urine and its application to a pharmacokinetic study of traumatic brain injury patients2
Determination of Cortisol in Hair Using Uhplc–Ms/Ms: Application to Patients Admitted for Ethanol Dependence Treatment2
Risk-Based Approach of Bioanalytical Methods for Clinical Immunogenicity Assessment of Multidomain Biotherapeutics2
Evaluating the Use of Locked Nucleic Acid Capture Probes in Hybrid LC–MS/MS Analysis of siRNA Analytes2
Efficiency of Pooled Surveillance Testing in Academic Labs to Detect and Inhibit Covid-19 Outbreaks2
Multi-Laboratory Evaluation of Immunoaffinity LC–MS-Based Glucagon-Like Peptide-1 Assay2
Lot-to-lot Reproducibility, Stability and Life Cycle Management of Antibody Reagents for Flow Cytometry2
Critical Reagents in Flow Cytometry, Instrumentation and Application in Drug Discovery Development2
Recent advances in gold nanoparticle-based colorimetric aptasensors for chemical and biological analyses2
Comparison of Pharmacokinetic Profiles in Hypoalbuminemia and Healthy Rats After Parecoxib Sodium Injection by LC–MS/MS2
A High-Speed Microscopy System Based on Deep Learning to Detect Yeast-Like Fungi Cells in Blood2
Recent advances and future perspectives of biosensing technologies in anti-doping applications2
Challenges with Development of a Pharmacokinetics Assay to Measure a Variably Glycosylated Fusion Protein2
Green Sample Preparation in Bioanalysis: Where Are We Now?2
WRIB Poster Awards Winners 20232
Pharmacokinetics and apparent Michaelis constant for metabolite conversion of sorafenib in healthy and hepatocellular carcinoma-bearing rats2
Preclinical Pharmacokinetics of 4-Hydroxy Isoleucine Using Lc–Ms/Ms: A Potential Polycystic Ovary Syndrome Phytopharmaceutical Therapeutics2
A Cell-Based FcRn-dependent Recycling assay for Predictive Pharmacokinetic assessment of Therapeutic Antibodies2
How the Covid-19 Pandemic is Changing Clinical Trial Conduct and Driving Innovation in Bioanalysis2
Determination of IQZ23 in Rat Plasma using LC-MS/MS: Consideration for Matrix Effect and Internal Standard Interference2
Effective Biomarker Measurement is Key for Biotherapeutic Development2
Monitoring of Hemoglobin and Erythropoiesis-Related mRNA with Dried Blood Spots in Athletes and Patients2
Introducing the 2023 Bioanalysis Special-Themed Issue on Laboratory Structure and Management for Nonregulated Bioanalysis2
A Novel Hydrophilic Interaction Chromatography Assay Characterization of 4-Pyridoxic Acid, an Emergent Renal Organic Anion Transporter 1/3 Transporter Biomarker2
UHPLC-MS/MS for Plasma Lamotrigine Analysis and Comparison with a Homogenous Enzyme Immunoassay2
Validation and Comprehensive Analysis of Streptococcus pneumoniae IgG WHO Enzyme-Linked Immunosorbent Assay in an Indian Reference Laboratory2
Quantitative Determination of Cpd118, A Novel FBPase Inhibitor, in Dog Plasma by HPLC–MS/MS2
Cloud Solutions for GxP Laboratories: Considerations for Data Storage2
Validation of Enantioseparation and Quantitation of an Active Metabolite of Abrocitinib in Human Plasma2
Handling Unstable Analytes: Literature Review and Expert Panel Survey by the Japan Bioanalysis Forum Discussion Group2
The Potential of Oral Fluid in 1Drug Monitoring: An Update2
Critical Reagent Characterization and Re-Evaluation to Ensure Long-Term Stability: Two Case Studies2
CRISPR in clinical diagnostics: bridging the gap between research and practice2
Determination of Levetiracetam by GC-MS and Effects of Storage Conditions and Gastric Digestive Systems on Drug Samples2
The synergy of nucleic acid amplification and miniaturized systems in enhancing liquid biopsy applications2
A comprehensive LC–MS based study of factors influencing biotinylation of critical reagents2
A Smartphone Digital Image Colorimetric Method Based on Nanoparticles for Determination of Lamotrigine2
Sensitive LC-MS/MS Quantification of Unconjugated Maytansinoid DM4 and its Metabolite S-methyl-DM4 in Human Plasma2
Determination of carbamazepine in fingerprints: a feasibility study to evaluate adherence in epilepsy patients2
Flow cytometry vs conventional methods for the evaluation of anti-PF4/heparin antibodies: a single center study2
A New Approach with Dried Plasma Spots: A Rapid Determination of Antidepressants and Antipsychotics by Fast GC–MS2
Ultrasensitive Digital Immunoassays for SOD1 Conformation in Amyotrophic Lateral Sclerosis2
Measurement of Free Fraction, Total Concentration and Protein Binding for Testosterone, Triiodothyronine and Thyroxine2
Development of a Sensitive HPLC Method with Fluorescence Detection for the Determination of Motilin in Human Plasma2
High-Sensitivity Workflow for LC–MS-Based Analysis of GALNAC-Conjugated Oligonucleotides: A Case Study2
Strategy and Validation of a Nonclinical Generic Plug-and-Play Antidrug Antibody Method for Human Monoclonal Antibody Biotherapeutics2
Hollow Fiber-in-Syringe Equilibrium Sampling Through Supported-Liquid Membrane for Evaluation of Drug-Plasma Binding2
Diversity and Inclusion in the Bioanalytical Industry: An Interview with Nigel Phillip Danielson-Ewing2
COVID-19: Bioanalytical Considerations, Contributions and Lessons–Part 12
A Survey of Pharmacokinetic Bioanalytical Methods in Biosimilar Biological License Applications for the Assessment of Target and Antidrug Antibody Effects2
A Singlicate Immunogenicity Method to Detect Anti-Polyethylene Glycol Antibodies: Pre- and Post-Dose of PEGylated Therapies2
Solid-Phase Extraction of Gallic Acid and Ascorbic Acid in Fruits Using Polymerized Deep Eutectic Solvent-Modified Substrate2
Flow Cytometry and Pharmacokinetics1
Diversity and Inclusion in the Bioanalytical Industry: An Interview with Shefali R Patel1
Bioanalysis Rising Star Award 2024: interviews with the finalists1
Molecularly imprinted polymer-based paper spray ionization mass spectrometry: shaping the future of bioanalysis1
Utilizing Droplet Digital Polymerase Chain Reaction for siRNA Quantitation in Rodent Plasma and Tissue Via Stem-Loop Reverse Transcription1
Characterization of Murine Lymphocyte Activation and Exhaustion Markers by a 14-Color Flow Cytometry Panel1
Insights and Future Trends in Bioanalysis: An Interview With Jing Tu1
Use of RNA biomarkers in the antidoping field1
A systematic and sensitive method for critical reagent antibody evaluation with PCA technology1
Measuring HSD17β13 protein turnover in mouse liver with D 2 O metabolic labeling and hybrid LC-MS1
An LC–MS/MS method for determination of the bromodomain inhibitor ZEN-3694 and its metabolite ZEN-3791 in human plasma1
Development and validation of an ultrasensitive qPCR method to identify and quantify EGFR T790M in cell-free DNA1
Evaluation of the light-initiated chemiluminescence assay for quantification of Humulus scandens pollen - specific IgE1
A Flow Cytometric Journey Into Cell Cycle Analysis1
A Review of Bioanalytical Applications of Microextraction Techniques Combined with Derivatization1
Observations from a decade of oligonucleotide bioanalysis by LC-MS1
Applying Contextofuse to Quantitative Polymerase Chain Reaction Method Validation and Analysis: A Recommendation From the European Bioanalysis Forum1
Bioanalytical LC–MS/MS method for simultaneous estimation of atorvastatin, its major active metabolites and ezetimibe1
Method development for the quantification of lead levels in whole blood sampled on Mitra ® with VAMS ® tips by inductively coupled1
Cross-validation of pharmacokinetic assays post-ICH M10 is not a pass/fail criterion1
pH-induced Homogeneous liquid–liquid Microextraction Method based on new Switchable Deep Eutectic Solvent for the Extraction of Three Antiepileptic Drugs from Breast Milk1
Systematic optimization of targeted and multiplexed MS-based screening workflows for protein biomarkers1
2021 White Paper on Recent Issues in Bioanalysis: ISR for Biomarkers, Liquid Biopsies, Spectral Cytometry, Inhalation/Oral & Multispecific Biotherapeutics, Accuracy/LLOQ for Flow Cytometry ( 1
Quantification of Abemaciclib and Metabolites: Evolution of Bioanalytical Methods Supporting a Novel Oncolytic Agent1
BiSim Tool: a binding simulation tool to aid and simplify ligand-binding assay design and development1
Lessons Learned from the COVID-19 Pandemic and its Impact on Bioanalysis and Drug Development1
Development of a validated novel bead extraction method for the detection of anti-PEG antibodies in human serum1
Quantification of MDR-TB drug JBD0131 and its metabolite in plasma via UPLC-MS/MS: application in first-in-human study1
The role of digital data management in today's collaborative drug discovery approach1
Bioanalysis of free antisense oligonucleotide payload from antibody–oligonucleotide conjugate by hybridization LC-MS/MS1
Introducing Dendritic Cell Antibody Internalization as an Immunogenicity Risk Assessment Tool1
Solving selectivity issues in LBAs: case study using Gyrolab to quantify CB307, a bispecific Humabody in human serum1
Olympic Anti-Doping Laboratory: The Analytical Technological Road From 2016 Rio De Janeiro to 2021 Tokyo1
Virus Reduction Neutralization Test and LI-COR Microneutralization Assay Bridging and WHO International Standard Calibration Studies for Respiratory Syncytial Virus1
Artificial intelligence and blockchain in clinical trials: enhancing data governance efficiency, integrity, and transparency1
A green bioanalytical spectrofluorimetric approach for estimation of Avapritinib anti-tumor drug; application to quality control and clinical studies1
Development and Validation of an LC-MS/MS Method for Determination of a Novel Anticancer Agent (CPI-613) in HumanPlasma1
Simultaneous Measurement of Mouse and Human Albumin in Chimeric Mice with Humanized Livers1
Surrogate Peptide Selection and Internal Standardization for Accurate Quantification of Endogenous Proteins1
Regen-Cov ® Antibody Cocktail Bioanalytical Strategy: Comparison of Lc-Mrm-Ms and Immunoassay Methods for Drug Quantification1
Glycoproteomic Bioanalysis of Exosomes by LC–MS for Early Diagnosis of Pancreatic Cancer1
Transforming drug discovery: the impact of AI and molecular simulation on R&D efficiency1
Pharmacokinetic analysis using single dilution assays: enhancing precision, reducing errors and increasing throughput1
Green HPLC method for determination of paracetamol and ibuprofen in human plasma: applications to pharmacokinetics1
The role of Ligand-Binding Assay and LC–MS in the Bioanalysis of Complex Protein and Oligonucleotide Therapeutics1
Quantitation of Reduced Il-33 Levels in Human Serum: Mitigating Interference From Endogenous Binding Partners1
Mitigating target interference challenges in bridging immunogenicity assay to detect anti-tocilizumab antibodies1
0.068006992340088